Dimerized Pentamethine Cyanines for Synergistically Boosting Photodynamic/Photothermal Therapy
Authors:
Open Access
Abstract
Photodynamic therapy (PDT) and photothermal therapy (PTT) have emerged promising applications in both fundamental research and clinical trials. However, it remains challenging to develop ideal photosensitizers (PSs) that concurrently integrate high photostability, large near‐infrared absorptivity, and efficient therapeutic capabilities. Herein, we reported a sample engineering strategy to afford a benzene‐fused Cy5 dimer (Cy‐D‐5) for synergistically boosting PDT/PTT applications. Intriguingly, Cy‐D‐5 exhibits a tendency to form both J‐aggregates and H‐aggregates in phosphate‐buffered saline, which show a long‐wavelength absorption band bathochromically shifted to 810 nm and a short‐wavelength absorption band hypsochromically shifted to 745 nm, respectively, when compared to its behavior in ethanol (778 nm). Density‐functional theory calculations combined with time‐resolved transient optical spectroscopy analysis reveal that the fused dimer Cy‐D‐5 exhibits a low ΔEST (0.51 eV) and efficient non‐radiative transition rates (12.6 times greater than that of the clinically approved PS‐indocyanine green [PS‐ICG]). Furthermore, the Cy‐D‐5 demonstrates a higher photosensitizing ability to produce 1O2, stronger photothermal conversion efficiency (η = 64.4%), and higher photostability compared with ICG. These combined properties enable Cy‐D‐5 to achieve complete tumor ablation upon 808 nm laser irradiation, highlighting its potential as a powerful and dual‐function phototherapeutic agent. This work may offer a practical strategy for engineering other existing dyes to a red‐shifted spectral range for various phototherapy applications.Keywords
Funding Information
- National Natural Science Foundation of China (22308220, 22090011)
This publication has 61 references indexed in Scilit:
- Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: The Development and Application of BODIPY@F127 NanoparticlesAdvanced Healthcare Materials, 2024
- “Three birds with one stone” nanoplatform: Efficient near‐infrared‐triggered type‑I AIE photosensitizer for mitochondria‐targeted photodynamic therapy against hypoxic tumorsAggregate, 2024
- Synergistic Inter‐ and Intramolecular Aggregation of Dimeric Cyanine Dyes Affords Highly Efficient In Vivo Self‐Delivery and Photothermal TherapyAdvanced Functional Materials, 2024
- Photoactivation Inducing Multifunctional Coupling of Fluorophore for Efficient Tumor Therapy In SituAdvanced Materials, 2024
- Heptamethine Cyanine Dyes with Ultra‐Efficient Excited‐State Nonradiative Decay for Synergistic Photothermal ImmunotherapyAdvanced Functional Materials, 2023
- Pyroptosis‐Mediated Synergistic Photodynamic and Photothermal Immunotherapy Enabled by a Tumor‐Membrane‐Targeted Photosensitive DimerAdvanced Materials, 2023
- Polyester‐tethered near‐infrared fluorophores confined in colloidal nanoparticles: Tunable and thermoresponsive aggregation and biomedical applicationsAggregate, 2022
- Strong π–π Stacking Stabilized Nanophotosensitizers: Improving Tumor Retention for Enhanced Therapy for Large Tumors in MiceAdvanced Materials, 2021
- Solutions to the Drawbacks of Photothermal and Photodynamic Cancer TherapyAdvanced Science, 2021
- NIR Light‐Driving Barrier‐Free Group Rotation in Nanoparticles with an 88.3% Photothermal Conversion Efficiency for Photothermal TherapyAdvanced Materials, 2020